Preclinical study demonstrates ultrasound-enhanced mitochondrial calcium overload and tumor suppression in cancer models, highlighting a dual-mode theranostic strategy.
Immunogenic cell death (ICD), a manner of tumor cell death that can trigger antitumor immune responses, has received extensive attention as a potential synergistic modality for cancer immunotherapy. Although many calcium ion (Ca²⁺) nanomodulators have been developed for cancer therapy through mitochondrial Ca²⁺ overload, their ICD-inducing properties have not been explored. Herein, an acid-sensitive PEG-decorated calcium carbonate (CaCO₃) nanoparticle incorporating curcumin (CUR; a Ca²⁺ enhancer) (PEGCaCUR) was prepared using a simple one-pot strategy. PEGCaCUR served as not only a Ca²⁺ nanomodulator inducing efficient mitochondrial Ca²⁺ overload but also an ICD inducer during improved synergistic cancer therapy. Combination of PEGCaCUR with ultrasound (US), PEGCaCUR+US, led to an enhanced ICD effect attributable to the enhanced mitochondrial Ca²⁺ overload, along with subsequent upregulation of reactive oxygen species levels. PEGCaCUR also facilitates photoacoustic/fluorescence dual-mode imaging, as well as effectively suppressing tumor growth and metastasis, indicating promising theranostic properties.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: